|
Press Releases |
|
 |
|
Friday, September 23, 2022 |
|
Malaysian Genomics Grows Presence in Thailand |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
Wednesday, September 21, 2022 |
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
Tuesday, August 30, 2022 |
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
Monday, August 29, 2022 |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
Thursday, August 18, 2022 |
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
Wednesday, July 20, 2022 |
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
Friday, July 15, 2022 |
|
Malaysian Genomics Appoints New Chairman |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
Wednesday, July 13, 2022 |
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
Friday, July 8, 2022 |
|
Malaysian Genomics Proposes Private Placement |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
Wednesday, July 6, 2022 |
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Reach Secures Major Investment to Accelerate Its Global Expansion and Fuel Enterprise Merchant Growth
Feb 20, 2025 23:00 HKT/SGT
|
|
|
HKTDC strengthens local competitiveness and global connections
Feb 20, 2025 22:09 HKT/SGT
|
|
|
Explore Cutting-Edge Cybersecurity Solutions at Exito's 25th Cyber Security Summit
Feb 20, 2025 17:06 HKT/SGT
|
|
|
Prioritise Self-Love and Self-Care This Year For A Better You
Feb 20, 2025 17:00 HKT/SGT
|
|
|
Eisai Selected for "Human Capital Leaders 2024" and "Human Capital Management Gold Quality" for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives
Feb 20, 2025 13:29 JST
|
|
|
New HKTDC Chairman appointed
Feb 19, 2025 23:44 HKT/SGT
|
|
|
Champion REIT Announces 2024 Annual Results
Feb 19, 2025 23:08 HKT/SGT
|
|
|
NEC X & Carbide Ventures Partner To Rapidly Accelerate Early-Stage Startups
Feb 19, 2025 20:16 JST
|
|
|
Mitsubishi Power Advances Bahrain's Industrial Growth with Completion of Alba's Power Station 5 Block 4 Combined Cycle Power Plant Project
Feb 19, 2025 16:54 JST
|
|
|
GA-ASI and CAE Sign Long-Term Agreement to Develop the Next Generation MQ-9B SkyGuardian(R) Mission Trainer
Feb 19, 2025 15:00 HKT/SGT
|
|
|
Goldman Sachs Raises Everest Medicines' Target Price to HK$48.32 on Stronger Commercial and R&D Outlook
Feb 19, 2025 14:42 HKT/SGT
|
|
|
Nissin Foods (Hong Kong) Charity Fund Supports Elite Athletes from The Education University of Hong Kong for the Third Consecutive Year
Feb 19, 2025 14:02 HKT/SGT
|
|
|
TrustCSI 3.0 Navigates the 'Belt and Road' and Empowers Global Enterprise's Digital Journey
Feb 19, 2025 12:41 HKT/SGT
|
|
|
GoDaddy Airo: An AI-Powered Revolutionary Solution for Asian Entrepreneurs and Small Business Owners
Feb 19, 2025 10:18 HKT/SGT
|
|
|
Honda Reveals Specification for its Next-generation Fuel Cell Module
Feb 19, 2025 11:07 JST
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|